Interferon Beta In Multiple Sclerosis Research Articles

A cost-utility analysis of interferon beta for multiple sclerosis.

A cost-utility analysis of interferon beta for multiple sclerosis.

Skin necrosis with subsequent formation of squamous cell carcinoma after subcutaneous interferon beta injection

A recent report reviewed cutaneous ulcerations caused by recombinant interferon beta injections in patients with multiple sclerosis.1 We describe a patient with multiple cutaneous ulcerations after injection of interferon beta for multiple sclerosis in whom a squamous cell carcinoma with perineural involvement occurred in an ulcer.

Skin necrosis with subsequent formation of squamous cell carcinoma after subcutaneous interferon beta injection

A recent report reviewed cutaneous ulcerations caused by recombinant interferon beta injections in patients with multiple sclerosis.1 We describe a patient with multiple cutaneous ulcerations after injection of interferon beta for multiple sclerosis in whom a squamous cell carcinoma with perineural involvement occurred in an ulcer.